Skip to main content
. 2019 Apr;10(2):300–306. doi: 10.21037/jgo.2018.11.08

Table 7. Stage-specific overall survival for neuroendocrine carcinomas.

Overall survival Stage I Stage II Stage III Stage IV
1-year OS 97.4% 100% 90.7% 54.8%
2-year OS 92.6% 93.5% 90.7% 54.8%
3-year OS 92.6% 93.5% 90.7% 27.4%
4-year OS 92.6% 93.5% 90.7% 27.4%